— Know what they know.
Not Investment Advice

CTRE NYSE

CareTrust REIT, Inc.
1W: -0.8% 1M: -2.4% 3M: -14.6% YTD: -0.5% 1Y: +2.8% 3Y: +82.5% 5Y: +107.7%
$36.14
-0.84 (-2.27%)
 
Weekly Expected Move ±3.0%
$34 $36 $37 $38 $39
NYSE · Real Estate · REIT - Healthcare Facilities · Tech Score Neutral · Power 49 · $8.5B mcap · 234M float · 1.06% daily turnover · Short 48% of daily vol
Credit Risk of going bust: not rated, financial company (lending is its business) Bonds: $44.7M held by 60 funds, 106 bp over Treasuries → details ▾
Not rated: lending and leverage are a financial company's business, which the model misreads.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
55.5 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 5.9%  ·  5Y Avg: 3.2%
Cost Advantage ★
70
Intangibles
58
Switching Cost
40
Network Effect
53
Scale
60
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CTRE has a Narrow competitive edge (55.5/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Cost Advantage. ROIC of 5.9% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$42
Low
$43
Avg Target
$45
High
Based on 7 analysts since Aug 6, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 13Hold: 5Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$43.43
Analysts7
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-19 Wells Fargo — $44 $43 -1 +17.6% $36.55
2026-10-13 Wedbush — $26 $44 +18 +20.1% $36.64
2026-10-05 BMO Capital — $47 $45 -2 +24.0% $36.30
2026-10-05 Raymond James David Rodgers $43 $42 -1 +15.7% $36.30
2026-09-01 Wells Fargo — $41 $44 +3 +13.0% $38.95
2026-08-14 RBC Capital Michael Carroll $44 $43 -1 +10.7% $38.83
2026-08-10 Cantor Fitzgerald — $42 $43 +1 +4.3% $41.22
2026-06-16 Raymond James David Rodgers $39 $43 +4 +16.1% $37.03
2026-06-15 BMO Capital — $43 $47 +4 +27.5% $36.85
2026-05-29 KeyBanc — $40 $46 +6 +12.7% $40.82
2026-05-22 Mizuho Securities Vikram Malhotra Initiated $45 — +9.7% $41.01
2026-02-24 RBC Capital Michael Carroll $23 $44 +21 +9.0% $40.36
2026-02-17 Cantor Fitzgerald — $37 $42 +5 +5.0% $40.01
2026-01-22 Goldman Sachs — Initiated $44 — +17.7% $37.39
2026-01-09 BMO Capital — Initiated $43 — +16.4% $36.93
2026-01-08 UBS — Initiated $43 — +15.4% $37.25
2025-12-15 Jefferies — Initiated $43 — +17.5% $36.59
2025-12-04 KeyBanc — $36 $40 +4 +6.1% $37.70
2025-11-25 Wells Fargo — Initiated $41 — +10.4% $37.13
2025-10-01 Cantor Fitzgerald — Initiated $37 — +6.7% $34.68
2025-09-02 Raymond James Jonathan Hughes $24 $39 +15 +13.6% $34.34
2025-08-14 KeyBanc Austin Wurschmidt $27 $36 +9 +7.9% $33.35
2024-07-01 Deutsche Bank Omotayo Okusanya Initiated $27 — +7.6% $25.10
2024-06-21 Robert W. Baird Amanda Sweiter Initiated $26 — +4.5% $24.88
2024-05-29 Wedbush Richard Anderson Initiated $26 — +3.1% $25.21
2024-05-08 KeyBanc Jordan Sadler Initiated $27 — +9.5% $24.66
2023-09-12 RBC Capital Michael Carroll Initiated $23 — +13.4% $20.28
2022-12-05 Raymond James — Initiated $24 — +20.8% $19.86

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A
Oct 27, 2026
DCF
5
ROE
4
ROA
5
D/E
5
P/E
2
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CTRE receives an overall rating of A. Strongest factors: DCF (5/5), ROE (4/5), ROA (5/5), D/E (5/5). Areas of concern: P/E (2/5), P/B (2/5).
Rating Change History
DateFromTo
2026-10-12 B+ A
2026-10-06 A- B+
2026-08-12 A A-
2026-08-10 B+ A
2026-08-07 A B+
2026-05-18 A- A
2026-05-11 B+ A-
2026-05-08 A- B+
2026-04-24 B+ A-
2026-04-01 A- B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 81 Grade A+
Profitability
74
Balance Sheet
66
Earnings Quality
72
Growth
76
Value
52
Momentum
100
Safety
100
Cash Flow
86
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CTRE scores highest in Safety (100/100) and lowest in Value (52/100). An overall grade of A+ places CTRE among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
4.23
Safe Zone
Piotroski F-Score
6/9
✓ ✓ ✓ ✓ ✓ ✗ ✗ ✗ ✓
Beneish M-Score
0.26
Possible Manipulator
Ohlson O-Score
-9.84
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA
Score: 88.4/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 1.26x
Accruals: -1.7%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CTRE scores 4.23, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CTRE scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CTRE's score of 0.26 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CTRE's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CTRE receives an estimated rating of AA (score: 88.4/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). CTRE's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
22.45x
PEG
0.68x
P/S
15.71x
P/B
1.88x
P/FCF
21.91x
P/OCF
21.15x
EV/EBITDA
20.08x
EV/Revenue
19.52x
EV/EBIT
25.61x
EV/FCF
24.59x
Earnings Yield
3.76%
FCF Yield
4.56%
Shareholder Yield
3.23%
Graham Number
$25.58
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 22.4x earnings, CTRE commands a growth premium. Graham's intrinsic value formula yields $25.58 per share, 41% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.977
NI / EBT
×
Interest Burden
0.878
EBT / EBIT
×
EBIT Margin
0.762
EBIT / Rev
×
Asset Turnover
0.103
Rev / Assets
×
Equity Multiplier
1.359
Assets / Equity
=
ROE
9.1%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CTRE's ROE of 9.1% is driven by EBIT Margin (0.762) as the dominant factor. A tax burden ratio of 0.98 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$58.41
Price/Value
0.69x
Margin of Safety
30.92%
Premium
-30.92%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with CTRE's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. CTRE actually compounded EPS at 64.4% over three years; the model uses 15%, the highest rate it will extrapolate — of 4,457 company-quarters that grew faster than 200%, none sustained it over the following seven years. CTRE trades at a -31% premium to its adjusted intrinsic value of $58.41, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 22.4x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$36.14
Median 1Y
$37.16
5th Pctile
$19.97
95th Pctile
$69.65
Ann. Volatility
38.5%
Analyst Target
$43.43
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
David M. Sedgwick
President and Chief Executive Officer
$1,000,000 $1,242,022 $10,002,522
William M. Wagner
Chief Financial Officer and Treasurer
$600,000 $575,135 $3,885,635
James B. Callister
Chief Investment Officer and Secretary
$600,000 $575,135 $3,885,635

CEO Pay Ratio

3117:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $10,002,522
Avg Employee Cost (SGA/emp): $3,209
Employees: 43

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
43
+104.8% YoY
Revenue / Employee
$11,083,395
Rev: $476,586,000
Profit / Employee
$7,454,372
NI: $320,538,000
SGA / Employee
$3,209
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 8.2% 7.9% 0.9% 0.9% -0.4% -0.9% 6.5% 4.1% 4.3% 4.7% 5.0% 5.4% 5.6% 5.8% 7.0% 8.4% 8.1% 9.2% 9.5% 9.1% 9.12%
ROA 4.8% 4.6% 0.5% 0.4% -0.2% -0.5% 3.4% 2.0% 2.5% 2.9% 3.2% 3.4% 4.2% 4.5% 5.2% 6.0% 6.5% 7.5% 7.3% 6.7% 6.71%
ROIC 6.8% 6.7% 6.6% 6.3% 4.9% 5.3% 7.1% 6.5% 6.7% 6.8% 6.6% 5.9% 5.2% 4.0% 3.7% 3.6% 4.3% 5.0% 5.9% 5.9% 5.93%
ROCE 6.5% 6.3% 2.2% 2.2% 1.6% 1.6% 6.2% 5.2% 4.9% 4.7% 4.5% 4.2% 4.7% 4.7% 5.0% 5.6% 6.1% 7.4% 7.7% 7.7% 7.66%
Gross Margin 97.9% 97.7% 95.9% 97.1% 90.4% 96.5% 96.0% 95.7% 93.3% 95.7% 95.4% 96.0% 90.2% 94.7% 97.0% 96.4% 97.5% 58.9% 56.9% 93.5% 93.45%
Operating Margin 58.1% 47.3% 46.7% 59.7% 53.4% 61.4% 58.5% 59.2% 57.1% 58.8% 57.5% 59.9% 54.0% 47.0% 59.5% 57.2% 57.1% 64.1% 65.1% 64.6% 64.64%
Net Margin 24.8% 37.2% -94.0% 44.2% 1.5% 30.2% 41.7% -1.0% 17.0% 49.2% 53.7% 19.4% 58.5% 83.8% 91.8% 79.7% 71.8% 82.4% 56.2% 55.2% 55.16%
EBITDA Margin 65.7% 77.4% -52.0% 84.5% 45.4% 75.4% 89.5% 48.8% 65.4% 89.3% 94.3% 59.5% 97.2% 1.2% 1.3% 1.2% 1.1% 1.1% 85.8% 84.6% 84.63%
FCF Margin 85.0% 79.3% 79.0% 78.1% 75.4% 73.1% 73.3% 70.5% 70.0% 72.4% 77.3% 86.0% 93.7% 1.0% 1.0% 1.1% 1.0% 95.5% 84.8% 79.4% 79.37%
OCF Margin 84.2% 82.5% 82.5% 81.4% 79.0% 77.0% 77.2% 75.9% 75.6% 77.9% 81.8% 88.8% 96.4% 1.1% 1.1% 1.1% 1.1% 99.3% 88.2% 82.3% 82.25%
ROE 3Y Avg snapshot only 6.14%
ROE 5Y Avg snapshot only 4.69%
ROA 3Y Avg snapshot only 4.49%
ROIC 3Y Avg snapshot only 4.46%
ROIC Economic snapshot only 5.89%
Cash ROA snapshot only 7.54%
Cash ROIC snapshot only 7.92%
CROIC snapshot only 7.64%
NOPAT Margin snapshot only 61.67%
Pretax Margin snapshot only 66.93%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only -0.91%
SBC / Revenue snapshot only 2.10%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 21.39 25.32 189.61 199.97 -417.15 -211.11 31.39 52.50 46.79 40.97 48.12 46.45 47.61 38.11 32.35 26.58 28.16 23.02 24.51 26.59 22.447
P/S Ratio 8.65 9.58 8.17 7.98 8.00 8.45 9.20 9.42 10.15 11.09 14.78 16.20 21.52 20.88 21.29 21.10 22.71 18.59 17.53 17.39 15.714
P/B Ratio 1.74 1.99 1.85 1.81 1.86 1.87 2.05 2.18 1.76 1.55 1.82 1.78 1.95 1.64 1.79 1.77 1.84 1.83 1.99 2.10 1.881
P/FCF 10.18 12.08 10.34 10.22 10.61 11.56 12.55 13.35 14.51 15.31 19.13 18.84 22.97 20.18 20.42 19.41 22.01 19.47 20.67 21.91 21.912
P/OCF 10.27 11.62 9.91 9.81 10.14 10.97 11.91 12.41 13.42 14.23 18.07 18.25 22.32 19.52 19.66 18.58 21.14 18.73 19.87 21.15 21.146
EV/EBITDA 14.74 16.39 25.55 26.81 30.43 31.43 17.58 21.75 19.02 17.17 20.58 22.09 25.42 23.40 24.09 20.85 19.76 17.48 17.94 20.08 20.083
EV/Revenue 12.20 13.02 11.69 12.03 12.07 12.22 12.94 14.05 13.22 12.60 15.48 17.02 21.61 21.69 24.52 24.17 23.27 20.34 18.97 19.52 19.519
EV/EBIT 22.93 25.89 70.02 73.69 101.56 101.81 27.25 36.47 30.33 26.45 31.10 32.74 35.89 32.00 31.87 26.52 25.10 21.89 22.76 25.61 25.605
EV/FCF 14.35 16.42 14.80 15.40 16.01 16.71 17.65 19.92 18.90 17.41 20.04 19.80 23.07 20.96 23.52 22.23 22.56 21.31 22.36 24.59 24.592
Earnings Yield 4.7% 3.9% 0.5% 0.5% -0.2% -0.5% 3.2% 1.9% 2.1% 2.4% 2.1% 2.2% 2.1% 2.6% 3.1% 3.8% 3.6% 4.3% 4.1% 3.8% 3.76%
FCF Yield 9.8% 8.3% 9.7% 9.8% 9.4% 8.7% 8.0% 7.5% 6.9% 6.5% 5.2% 5.3% 4.4% 5.0% 4.9% 5.2% 4.5% 5.1% 4.8% 4.6% 4.56%
PEG Ratio snapshot only 0.679
Price/Tangible Book snapshot only 2.128
EV/OCF snapshot only 23.731
EV/Gross Profit snapshot only 25.672
Acquirers Multiple snapshot only 30.888
Shareholder Yield snapshot only 3.23%
Graham Number snapshot only $25.58
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 0.28 0.21 1.12 0.71 0.43 0.15 0.40 0.11 0.75 4.39 6.07 6.42 3.96 3.33 6.55 2.62 4.76 1.54 1.75 1.20 1.200
Quick Ratio 0.28 0.21 1.12 0.71 0.43 0.15 0.40 0.11 0.75 4.39 6.07 6.42 3.96 3.33 6.55 2.62 4.76 1.54 1.75 1.20 1.200
Debt/Equity 0.73 0.74 0.83 0.95 0.95 0.85 0.87 1.08 0.54 0.42 0.36 0.35 0.16 0.14 0.28 0.35 0.22 0.22 0.22 0.27 0.268
Net Debt/Equity 0.71 0.71 0.80 0.92 0.95 0.83 0.84 1.07 0.53 0.21 0.09 0.09 0.01 0.06 0.27 0.26 0.05 0.17 0.16 0.26 0.257
Debt/Assets 0.41 0.41 0.44 0.47 0.47 0.44 0.45 0.50 0.34 0.29 0.25 0.25 0.14 0.12 0.21 0.25 0.18 0.17 0.17 0.20 0.203
Debt/EBITDA 4.40 4.46 7.99 9.37 10.33 9.87 5.28 7.18 4.44 4.08 3.85 4.08 2.13 1.88 3.28 3.60 2.34 1.94 1.81 2.28 2.282
Net Debt/EBITDA 4.28 4.33 7.69 9.02 10.26 9.69 5.08 7.17 4.42 2.07 0.93 1.07 0.11 0.87 3.17 2.65 0.47 1.51 1.36 2.19 2.188
Interest Coverage 4.17 4.04 1.35 1.32 0.86 0.75 2.61 1.87 1.99 2.31 2.61 3.01 3.95 5.10 6.59 7.63 8.02 8.44 8.08 8.19 8.193
Equity Multiplier 1.79 1.79 1.89 2.01 2.02 1.91 1.93 2.14 1.59 1.47 1.40 1.39 1.21 1.18 1.33 1.41 1.27 1.28 1.27 1.32 1.320
Cash Ratio snapshot only 0.095
Debt Service Coverage snapshot only 10.445
Cash to Debt snapshot only 0.041
FCF to Debt snapshot only 0.358
Defensive Interval snapshot only 3260.8 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.12 0.12 0.12 0.11 0.11 0.11 0.12 0.11 0.11 0.11 0.10 0.10 0.09 0.08 0.08 0.08 0.08 0.09 0.10 0.10 0.103
Inventory Turnover — — — — — — — — — — — — — — — — — — — — —
Receivables Turnover (trade) 66.42 89.69 132.15 142.82 88.25 132.33 241.99 298.89 323.76 489.76 488.58 288.06 347.37 290.96 209.17 146.46 78.39 7.65 57.02 52.63 52.627
Payables Turnover 0.15 0.16 0.23 0.28 0.31 0.38 0.39 0.47 0.30 0.33 0.34 0.36 0.32 0.30 0.31 0.19 0.15 0.72 1.62 1.14 1.144
DSO (trade) 5 4 3 3 4 3 2 1 1 1 1 1 1 1 2 2 5 48 6 7 6.9 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 2463 2297 1565 1322 1192 969 936 777 1216 1110 1062 1021 1140 1216 1188 1894 2513 510 225 319 319.1 days
Cash Conversion Cycle (trade) -2458 -2293 -1562 -1319 -1188 -966 -935 -776 -1215 -1109 -1062 -1020 -1139 -1215 -1187 -1892 -2508 -462 -218 -312 -312.2 days
Cash Velocity snapshot only 11.031
Capital Intensity snapshot only 10.910
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 6.1% 8.3% 7.4% 4.1% 2.2% -1.4% -1.7% -0.7% 2.0% 5.9% 9.7% 13.3% 13.9% 14.9% 19.7% 29.7% 47.6% 73.9% 90.0% 96.2% 96.17%
Net Income -7.1% -11.0% -90.0% -91.0% -1.0% -1.1% 5.7% 3.5% 12.5% 8.2% 15.0% 1.2% 1.4% 1.3% 1.6% 2.0% 1.6% 1.6% 1.1% 61.6% 61.60%
EPS -8.1% -12.2% -90.1% -91.1% -1.0% -1.1% 5.5% 3.3% 11.7% 7.6% -14.4% 50.2% 54.9% 35.8% 82.2% 1.2% 98.3% 1.3% 72.9% 33.0% 33.04%
FCF 21.0% 3.5% 4.6% -1.8% -9.3% -9.1% -8.8% -10.4% -5.4% 4.9% 15.7% 38.0% 52.5% 64.3% 61.4% 63.9% 62.6% 60.5% 54.6% 43.3% 43.26%
EBITDA -3.2% -4.0% -44.6% -47.2% -51.0% -51.8% 58.0% 43.0% 78.8% 1.0% 12.2% 35.1% 39.3% 45.1% 61.9% 95.1% 1.0% 1.2% 97.3% 64.5% 64.52%
Op. Income 7.7% 2.4% -2.9% -5.7% -9.0% -0.6% 9.3% 9.0% 16.4% 11.7% 9.5% 13.7% 11.0% 6.9% 13.5% 21.9% 43.0% 91.8% 1.1% 1.3% 1.26%
OCF Growth snapshot only 42.07%
Asset Growth snapshot only 27.33%
Equity Growth snapshot only 36.08%
Debt Growth snapshot only 4.30%
Shares Change snapshot only 21.46%
Dividend Growth snapshot only 18.57%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 6.9% 7.0% 6.7% 5.2% 6.4% 5.6% 4.8% 5.4% 3.4% 4.2% 5.0% 5.4% 5.9% 6.3% 8.9% 13.4% 19.7% 28.4% 35.6% 42.3% 42.30%
Revenue 5Y 13.5% 12.8% 11.5% 10.1% 9.0% 7.4% 6.3% 5.4% 4.9% 5.0% 5.6% 5.5% 7.0% 7.5% 8.6% 11.5% 13.2% 17.7% 21.4% 24.4% 24.39%
EPS 3Y 12.3% 2.7% -49.8% -51.8% — — 2.1% -12.7% -22.0% -15.8% -18.0% -16.4% -7.2% -2.7% 1.2% 1.4% — — 39.2% 64.4% 64.42%
EPS 5Y 11.5% 9.1% -30.0% -27.5% — — 6.8% -8.9% -6.1% -6.0% -6.8% -6.0% 7.4% 7.1% 10.7% 17.3% 7.8% 13.1% 11.7% 11.6% 11.56%
Net Income 3Y 18.8% 7.5% -48.2% -51.3% — — 3.5% -11.5% -19.6% -12.7% -8.3% -4.1% 9.9% 20.2% 1.7% 2.1% — — 82.6% 1.2% 1.19%
Net Income 5Y 23.6% 19.7% -24.8% -23.3% — — 12.7% -4.0% -1.3% -1.5% 1.3% 2.5% 19.2% 22.0% 26.7% 35.1% 26.6% 31.7% 32.5% 33.3% 33.31%
EBITDA 3Y 9.8% 5.3% -13.1% -15.6% -18.0% -20.1% -2.1% -5.6% -5.4% -2.5% -0.6% 0.6% 6.9% 11.9% 42.1% 55.6% 72.1% 85.1% 53.0% 63.0% 63.05%
EBITDA 5Y 13.9% 13.9% 0.5% -1.3% -4.8% -5.8% 5.7% 2.2% 3.0% 2.4% 3.1% 3.0% 6.6% 8.2% 11.2% 17.3% 19.3% 24.0% 25.7% 26.7% 26.74%
Gross Profit 3Y 9.9% 9.9% 8.9% 6.4% 6.6% 5.2% 4.2% 4.7% 2.9% 3.4% 4.1% 4.4% 4.5% 4.8% 7.8% 12.5% 20.2% 23.3% 24.7% 32.3% 32.27%
Gross Profit 5Y 15.5% 14.8% 13.2% 11.8% 10.1% 8.6% 7.4% 6.4% 6.1% 6.1% 6.3% 5.8% 6.9% 7.0% 8.2% 11.1% 13.1% 14.3% 14.8% 18.2% 18.25%
Op. Income 3Y 16.1% 8.3% 5.4% 3.3% 5.7% 6.9% 7.7% 8.7% 4.5% 4.4% 5.1% 5.3% 5.5% 5.9% 10.8% 14.7% 22.7% 31.8% 38.2% 46.3% 46.30%
Op. Income 5Y 17.1% 14.8% 12.0% 10.7% 9.0% 12.6% 12.5% 11.2% 10.6% 7.1% 7.0% 6.5% 8.8% 7.8% 9.2% 12.2% 12.6% 18.5% 22.9% 26.4% 26.36%
FCF 3Y 19.1% 15.6% 13.3% 8.8% 6.3% 4.5% 3.0% 2.8% 1.3% -0.4% 3.3% 6.7% 9.4% 16.1% 19.4% 26.6% 32.9% 40.3% 42.4% 48.0% 48.00%
FCF 5Y 21.0% 18.6% 16.8% 12.9% 11.8% 9.2% 8.8% 9.3% 7.7% 8.1% 8.9% 9.8% 11.6% 14.5% 15.3% 19.7% 20.8% 21.1% 22.4% 23.3% 23.34%
OCF 3Y 18.2% 16.4% 13.6% 9.1% 6.9% 4.6% 3.0% 2.6% 1.5% 2.0% 5.6% 8.5% 10.8% 15.9% 19.2% 26.7% 32.7% 39.7% 41.8% 46.2% 46.18%
OCF 5Y 20.7% 19.5% 17.7% 13.7% 12.8% 10.2% 9.8% 10.7% 9.1% 9.3% 9.4% 9.8% 11.6% 14.1% 15.0% 18.9% 20.1% 22.0% 23.6% 24.7% 24.68%
Assets 3Y 9.8% 8.3% 1.5% 3.2% 2.6% 2.2% 1.9% 6.2% 6.7% 11.5% 12.8% 12.2% 21.1% 27.9% 34.6% 40.3% 45.7% 47.0% 47.8% 50.6% 50.57%
Assets 5Y 14.2% 12.1% 10.5% 10.4% 7.9% 6.5% 5.9% 7.5% 7.3% 10.0% 9.0% 12.0% 13.9% 17.7% 20.5% 26.3% 28.5% 27.9% 26.2% 25.4% 25.40%
Equity 3Y 8.4% 6.0% 1.4% -4.4% -4.3% -2.9% -3.0% -3.9% 6.6% 15.7% 21.8% 27.9% 38.2% 47.0% 51.3% 57.9% 70.0% 68.1% 70.0% 76.8% 76.78%
Book Value 3Y 2.5% 1.3% -1.7% -5.2% -4.8% -3.6% -4.3% -5.2% 3.4% 11.6% 9.0% 11.4% 16.7% 19.0% 21.3% 25.4% 30.7% 31.3% 29.6% 32.7% 32.71%
Dividend 3Y -2.6% -2.0% -0.6% 1.4% 1.5% 1.0% 0.1% 0.1% -1.6% -0.8% -6.0% -5.6% -5.3% -7.5% -7.8% -8.4% -11.7% -10.5% -13.3% -15.2% -15.22%
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.95 0.95 0.96 0.93 0.96 0.94 0.93 0.91 0.95 0.93 0.93 0.89 0.92 0.89 0.85 0.79 0.65 0.60 0.60 0.61 0.609
Earnings Stability 0.84 0.77 0.00 0.00 0.01 0.02 0.00 0.13 0.08 0.11 0.01 0.02 0.02 0.08 0.33 0.37 0.37 0.45 0.62 0.67 0.669
Margin Stability 0.96 0.96 0.96 0.97 0.97 0.97 0.97 0.97 0.97 0.97 0.98 0.98 0.98 0.98 0.99 0.99 0.99 0.94 0.89 0.90 0.903
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 1.00 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.97 0.96 0.50 0.50 0.20 0.20 0.50 0.50 0.20 0.20 0.94 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness 0.93 0.88 0.00 0.00 — — 0.00 0.00 — — 0.86 0.25 0.19 0.20 0.12 0.01 0.10 0.12 0.30 0.53 0.529
ROE Trend 0.02 0.01 -0.06 -0.06 -0.09 -0.09 0.02 -0.01 -0.00 0.00 0.00 0.01 0.02 0.03 0.00 0.03 0.03 0.04 0.03 0.03 0.027
Gross Margin Trend 0.02 0.01 0.00 -0.00 -0.02 -0.03 -0.03 -0.03 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.00 0.00 0.02 -0.11 -0.21 -0.19 -0.190
FCF Margin Trend 0.10 0.00 -0.00 -0.01 -0.04 -0.08 -0.07 -0.10 -0.10 -0.04 0.01 0.12 0.21 0.31 0.29 0.30 0.21 0.08 -0.06 -0.18 -0.180
Sustainable Growth Rate -2.6% -3.1% -10.7% -10.9% — — -6.2% -9.1% -7.1% -5.5% -4.9% -4.6% -3.1% -2.2% -1.2% 0.3% 0.8% 1.8% 1.6% 1.3% 1.29%
Internal Growth Rate — — — — — — — — — — — — — — — 0.2% 0.7% 1.4% 1.2% 1.0% 0.96%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 2.08 2.18 19.13 20.39 -41.15 -19.24 2.64 4.23 3.49 2.88 2.66 2.54 2.13 1.95 1.65 1.43 1.33 1.23 1.23 1.26 1.258
FCF/OCF 1.01 0.96 0.96 0.96 0.96 0.95 0.95 0.93 0.92 0.93 0.94 0.97 0.97 0.97 0.96 0.96 0.96 0.96 0.96 0.97 0.965
FCF/Net Income snapshot only 1.214
OCF/EBITDA snapshot only 0.846
CapEx/Revenue 0.8% 3.2% 3.5% 3.3% 3.5% 3.9% 3.9% 5.3% 5.7% 5.5% 4.5% 2.8% 2.7% 3.5% 4.0% 4.9% 4.3% 3.8% 3.4% 2.9% 2.88%
CapEx/Depreciation snapshot only 0.137
Accruals Ratio -0.05 -0.05 -0.09 -0.08 -0.09 -0.09 -0.06 -0.06 -0.06 -0.05 -0.05 -0.05 -0.05 -0.04 -0.03 -0.03 -0.02 -0.02 -0.02 -0.02 -0.017
Sloan Accruals snapshot only -0.056
Cash Flow Adequacy snapshot only 1.393
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 6.2% 5.5% 6.6% 6.9% 7.0% 6.7% 6.2% 6.1% 5.6% 5.2% 4.1% 4.0% 3.3% 3.6% 3.6% 3.6% 3.2% 3.5% 3.4% 3.2% 4.16%
Dividend/Share $1.03 $1.04 $1.07 $1.08 $1.09 $1.09 $1.08 $1.10 $1.05 $1.09 $0.94 $0.95 $0.97 $0.95 $1.01 $1.10 $1.10 $1.27 $1.25 $1.30 $1.50
Payout Ratio 1.3% 1.4% 12.5% 13.7% — — 2.0% 3.2% 2.6% 2.1% 2.0% 1.9% 1.6% 1.4% 1.2% 96.3% 89.6% 80.9% 83.5% 85.9% 85.87%
FCF Payout Ratio 63.0% 66.8% 68.2% 70.1% 73.8% 77.4% 78.1% 81.6% 81.4% 80.3% 78.3% 75.1% 75.3% 72.9% 74.0% 70.4% 70.1% 68.4% 70.4% 70.7% 70.75%
Total Payout Ratio 1.3% 1.4% 12.8% 14.3% — — 2.0% 3.3% 2.7% 2.2% 2.0% 1.9% 1.6% 1.4% 1.2% 97.9% 90.9% 82.0% 83.6% 85.9% 85.91%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 0.15 0.14 0.14 0.14 0.13 0.12 0.11 0.10 0.10 0.14 0.20 0.31 0.44 0.53 0.56 0.57 0.54 0.54 0.51 0.47 0.473
Buyback Yield 0.1% 0.1% 0.2% 0.3% 0.3% 0.3% 0.2% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.1% 0.1% 0.2% 0.3% 0.3% 0.3% 0.2% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% -5.9% -14.3% -14.3% -14.4% -12.6% -12.60%
Total Shareholder Return 6.3% 5.6% 6.8% 7.2% 7.2% 7.0% 6.4% 6.2% 5.7% 5.3% 4.2% 4.1% 3.3% 3.7% 3.7% -2.3% -11.1% -10.7% -11.0% -9.4% -9.37%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.01 1.01 1.01 1.00 0.99 0.99 0.98 0.98 0.977
Interest Burden (EBT/EBIT) 0.76 0.75 0.26 0.24 -0.16 -0.33 0.62 0.47 0.50 0.57 0.62 0.67 0.75 0.80 0.85 0.87 0.88 0.88 0.88 0.88 0.878
EBIT Margin 0.53 0.50 0.17 0.16 0.12 0.12 0.47 0.39 0.44 0.48 0.50 0.52 0.60 0.68 0.77 0.91 0.93 0.93 0.83 0.76 0.762
Asset Turnover 0.12 0.12 0.12 0.11 0.11 0.11 0.12 0.11 0.11 0.11 0.10 0.10 0.09 0.08 0.08 0.08 0.08 0.09 0.10 0.10 0.103
Equity Multiplier 1.69 1.72 1.82 2.04 1.90 1.85 1.91 2.07 1.77 1.64 1.58 1.61 1.33 1.28 1.35 1.40 1.25 1.24 1.29 1.36 1.359
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $0.78 $0.75 $0.09 $0.08 $-0.04 $-0.08 $0.55 $0.34 $0.40 $0.51 $0.47 $0.51 $0.62 $0.69 $0.87 $1.14 $1.23 $1.57 $1.50 $1.52 $1.52
Book Value/Share $9.53 $9.48 $8.76 $8.68 $8.42 $8.73 $8.48 $8.20 $10.64 $13.35 $12.57 $13.38 $15.15 $15.98 $15.62 $17.11 $18.82 $19.77 $18.45 $19.17 $19.31
Tangible Book/Share $9.52 $9.47 $8.73 $8.65 $8.39 $8.70 $8.45 $8.17 $10.61 $13.30 $12.53 $13.38 $15.15 $15.96 $15.60 $16.91 $18.59 $19.54 $18.45 $18.96 $18.96
Revenue/Share $1.92 $1.97 $1.98 $1.97 $1.96 $1.93 $1.89 $1.90 $1.85 $1.87 $1.55 $1.47 $1.37 $1.25 $1.31 $1.44 $1.53 $1.95 $2.09 $2.32 $2.32
FCF/Share $1.63 $1.56 $1.57 $1.54 $1.47 $1.41 $1.39 $1.34 $1.29 $1.35 $1.19 $1.26 $1.29 $1.30 $1.37 $1.56 $1.58 $1.86 $1.77 $1.84 $1.85
OCF/Share $1.62 $1.62 $1.63 $1.60 $1.54 $1.48 $1.46 $1.44 $1.40 $1.46 $1.26 $1.31 $1.32 $1.34 $1.42 $1.63 $1.64 $1.93 $1.84 $1.91 $1.91
Cash/Share $0.18 $0.21 $0.28 $0.31 $0.05 $0.14 $0.28 $0.01 $0.03 $2.77 $3.39 $3.41 $2.36 $1.17 $0.14 $1.59 $3.36 $0.97 $1.00 $0.21 $0.21
EBITDA/Share $1.59 $1.56 $0.91 $0.88 $0.78 $0.75 $1.39 $1.23 $1.28 $1.37 $1.16 $1.13 $1.17 $1.16 $1.34 $1.66 $1.80 $2.26 $2.21 $2.25 $2.25
Debt/Share $6.99 $6.97 $7.25 $8.27 $8.01 $7.40 $7.36 $8.83 $5.71 $5.61 $4.47 $4.62 $2.48 $2.18 $4.39 $5.99 $4.21 $4.38 $3.99 $5.14 $5.14
Net Debt/Share $6.81 $6.77 $6.97 $7.96 $7.96 $7.26 $7.08 $8.82 $5.67 $2.84 $1.09 $1.21 $0.12 $1.01 $4.25 $4.40 $0.85 $3.41 $3.00 $4.93 $4.93
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 4.229
Altman Z-Prime snapshot only 7.317
Piotroski F-Score 4 4 5 5 4 2 5 4 7 6 5 7 6 5 7 6 7 5 6 6 6
Beneish M-Score 248.53 -2.73 -3.29 -3.35 -3.61 -3.61 -3.25 -3.21 -3.54 -2.72 -2.73 -1.18 1.48 191.26 165.38 51.19 57.65 -1.04 -1.39 0.26 0.261
Ohlson O-Score snapshot only -9.843
ROIC (Greenblatt) snapshot only 3.98%
Net-Net WC snapshot only $-3.38
EVA snapshot only $-229585135.54
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only AA
Credit Score 46.68 44.77 33.22 23.71 21.61 23.46 34.55 27.98 44.52 67.38 73.48 75.37 87.13 91.53 86.40 81.59 91.64 90.79 90.84 88.40 88.397
Credit Grade snapshot only 3
Credit Trend snapshot only 6.807
Implied Spread (bps) snapshot only 80.000
Industry Credit Rank snapshot only 100
Sector Credit Rank snapshot only 93

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms